These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 30872395)

  • 1. Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis.
    Liao L; Schneider KM; Galvez EJC; Frissen M; Marschall HU; Su H; Hatting M; Wahlström A; Haybaeck J; Puchas P; Mohs A; Peng J; Bergheim I; Nier A; Hennings J; Reißing J; Zimmermann HW; Longerich T; Strowig T; Liedtke C; Cubero FJ; Trautwein C
    Gut; 2019 Aug; 68(8):1477-1492. PubMed ID: 30872395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.
    Tedesco D; Thapa M; Chin CY; Ge Y; Gong M; Li J; Gumber S; Speck P; Elrod EJ; Burd EM; Kitchens WH; Magliocca JF; Adams AB; Weiss DS; Mohamadzadeh M; Grakoui A
    Gastroenterology; 2018 Jun; 154(8):2178-2193. PubMed ID: 29454797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2
    Fuchs CD; Dixon ED; Hendrikx T; Mlitz V; Wahlström A; Ståhlman M; Scharnagl H; Stojakovic T; Binder CJ; Marschall HU; Trauner M
    Hepatol Commun; 2022 Sep; 6(9):2368-2378. PubMed ID: 35691019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
    Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
    J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD.
    Pierantonelli I; Rychlicki C; Agostinelli L; Giordano DM; Gaggini M; Fraumene C; Saponaro C; Manghina V; Sartini L; Mingarelli E; Pinto C; Buzzigoli E; Trozzi L; Giordano A; Marzioni M; Minicis S; Uzzau S; Cinti S; Gastaldelli A; Svegliati-Baroni G
    Sci Rep; 2017 Sep; 7(1):12200. PubMed ID: 28939830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
    Fickert P; Fuchsbichler A; Wagner M; Zollner G; Kaser A; Tilg H; Krause R; Lammert F; Langner C; Zatloukal K; Marschall HU; Denk H; Trauner M
    Gastroenterology; 2004 Jul; 127(1):261-74. PubMed ID: 15236191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota as a cornerstone in the development of primary sclerosing cholangitis: paving the path for translational diagnostic and therapeutic approaches.
    Mooser C; Ganal-Vonarburg SC
    Gut; 2019 Aug; 68(8):1353-1355. PubMed ID: 31028154
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatoprotective effects of Huangqi decoction (Astragali Radix and Glycyrrhizae Radix et Rhizoma) on cholestatic liver injury in mice: Involvement of alleviating intestinal microbiota dysbiosis.
    Zou J; Li W; Wang G; Fang S; Cai J; Wang T; Zhang H; Liu P; Wu J; Ma Y
    J Ethnopharmacol; 2021 Mar; 267():113544. PubMed ID: 33152436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis.
    Meadows V; Marakovits C; Ekser B; Kundu D; Zhou T; Kyritsi K; Pham L; Chen L; Kennedy L; Ceci L; Wu N; Carpino G; Zhang W; Isidan A; Meyer A; Owen T; Gaudio E; Onori P; Alpini G; Francis H
    Am J Physiol Gastrointest Liver Physiol; 2023 Jan; 324(1):G60-G77. PubMed ID: 36410025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of neutrophil extracellular trap components ameliorates cholestatic liver disease in Mdr2 (Abcb4) knockout mice.
    Hintermann E; Tondello C; Fuchs S; Bayer M; Pfeilschifter JM; Taubert R; Mollenhauer M; Elferink RPJO; Manns MP; Christen U
    J Autoimmun; 2024 Jun; 146():103229. PubMed ID: 38653165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leaky Gut Driven by Dysbiosis Augments Activation and Accumulation of Liver Macrophages
    Zhang H; Liu M; Zhong W; Zheng Y; Li Y; Guo L; Zhang Y; Ran Y; Zhao J; Zhou L; Wang B
    Front Immunol; 2021; 12():624360. PubMed ID: 33841405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile acids modulate colonic MAdCAM-1 expression in a murine model of combined cholestasis and colitis.
    Gao RY; Shearn CT; Orlicky DJ; Battista KD; Alexeev EE; Cartwright IM; Lanis JM; Kostelecky RE; Ju C; Colgan SP; Fennimore BP
    Mucosal Immunol; 2021 Mar; 14(2):479-490. PubMed ID: 33004979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis.
    Tabibian JH; O'Hara SP; Trussoni CE; Tietz PS; Splinter PL; Mounajjed T; Hagey LR; LaRusso NF
    Hepatology; 2016 Jan; 63(1):185-96. PubMed ID: 26044703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut-Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology.
    Maroni L; Ninfole E; Pinto C; Benedetti A; Marzioni M
    Cells; 2020 Mar; 9(3):. PubMed ID: 32192118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colesevelam attenuates cholestatic liver and bile duct injury in
    Fuchs CD; Paumgartner G; Mlitz V; Kunczer V; Halilbasic E; Leditznig N; Wahlström A; Ståhlman M; Thüringer A; Kashofer K; Stojakovic T; Marschall HU; Trauner M
    Gut; 2018 Sep; 67(9):1683-1691. PubMed ID: 29636383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis.
    Strack I; Schulte S; Varnholt H; Schievenbusch S; Töx U; Wendland K; Steffen HM; Drebber U; Dienes HP; Odenthal M
    Lab Invest; 2011 Feb; 91(2):252-61. PubMed ID: 20921947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis.
    Tardelli M; Bruschi FV; Fuchs CD; Claudel T; Auer N; Kunczer V; Baumgartner M; A H O Ronda O; Verkade HJ; Stojakovic T; Scharnagl H; Habib A; Zimmermann R; Lotersztajn S; Trauner M
    Hepatology; 2020 May; 71(5):1750-1765. PubMed ID: 31505038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of microRNA-24 increases liver fibrosis by enhanced menin expression in Mdr2
    Hall C; Ehrlich L; Meng F; Invernizzi P; Bernuzzi F; Lairmore TC; Alpini G; Glaser S
    J Surg Res; 2017 Sep; 217():160-169. PubMed ID: 28602220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2
    Kyritsi K; Francis H; Zhou T; Ceci L; Wu N; Yang Z; Meng F; Chen L; Baiocchi L; Kundu D; Kennedy L; Liangpunsakul S; Wu C; Glaser S; Alpini G
    Gene Expr; 2020 Nov; 20(2):89-103. PubMed ID: 32393417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.